Impact of Megatherapy On Survival After Relapse From Stage 4 Neuroblastoma in Patients Over 1 Year of Age At Diagnosis - a Report From the European Group for Bone-Marrow Transplantation

Ladenstein, R, Lasset, C, Hartmann, O, Frappaz, D, Garaventa, A, Klingebiel, T, Zucker, JM, Coze, C, Burdach, S, Gadner, H, Paolucci, P, Pearson, A, Pinkerton, R, Chauvin, F and Philip, T (1993) Impact of Megatherapy On Survival After Relapse From Stage 4 Neuroblastoma in Patients Over 1 Year of Age At Diagnosis - a Report From the European Group for Bone-Marrow Transplantation. Journal of Clinical Oncology, 11 12: 2330-2341.

Author Ladenstein, R
Lasset, C
Hartmann, O
Frappaz, D
Garaventa, A
Klingebiel, T
Zucker, JM
Coze, C
Burdach, S
Gadner, H
Paolucci, P
Pearson, A
Pinkerton, R
Chauvin, F
Philip, T
Title Impact of Megatherapy On Survival After Relapse From Stage 4 Neuroblastoma in Patients Over 1 Year of Age At Diagnosis - a Report From the European Group for Bone-Marrow Transplantation
Journal name Journal of Clinical Oncology   Check publisher's open access policy
ISSN 0732-183X
Publication date 1993-12
Sub-type Article (original research)
Volume 11
Issue 12
Start page 2330
End page 2341
Total pages 12
Language eng
Keyword Advanced Neuro-Blastoma
Acute Lymphoblastic-Leukemia
High-Dose Melphalan
Total-Body Irradiation
Improved Response Rate
Metastatic Neuroblastoma
Phase-I
Autologous Marrow
Unselected Group
Clinical-Trials
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 33 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 08 Jul 2016, 18:02:59 EST by System User